Tetra Radar · FDA Approvals · Decision date
tabelecleucel: FDA decision date
Atara Biotherapeutics Inc (ATRA) · 31 March 2027
The BLA has a Class 2 Resubmission Prescription Drug User Fee Act (PDUFA) target action date of March 31, 2027.
Source: 8-K of 10 November 2026
The decision is pending.
Atara Biotherapeutics Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.